SRI International
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1946-11-06
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.sri.com
Clinical Trials
8
Active:0
Completed:3
Trial Phases
3 Phases
Phase 1:2
Phase 2:1
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (57.1%)Phase 1
2 (28.6%)Phase 2
1 (14.3%)Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System
Terminated
- Conditions
- Anthrax
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- SRI International
- Target Recruit Count
- 343
- Registration Number
- NCT05672875
- Locations
- 🇺🇸
WellNow Urgent Care and Research, Dayton, Ohio, United States
Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- SRI International
- Target Recruit Count
- 42
- Registration Number
- NCT05628961
- Locations
- 🇺🇸
SRI Biosciences Clinical Trials Unit, Plymouth, Michigan, United States
Sleep and Emotional Reactivity in Alcohol Use Disorder
Not Applicable
- Conditions
- Alcohol Use Disorder (AUD)
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- SRI International
- Target Recruit Count
- 100
- Registration Number
- NCT04979507
- Locations
- 🇺🇸
SRI International, Menlo Park, California, United States
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine
Phase 1
- Conditions
- EncephalomyelitisBrain DiseasesCentral Nervous System DiseasesCentral Nervous System InfectionsCentral Nervous System Viral DiseasesTogaviridae InfectionsEncephalitisEncephalitis, ViralInfectious EncephalitisVirus Diseases
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- SRI International
- Target Recruit Count
- 48
- Registration Number
- NCT03776994
- Locations
- 🇺🇸
SRI Biosciences Clinical Trials Unit, Plymouth, Michigan, United States
Sleep and Cardiovascular Health in Adolescence
Not Applicable
Completed
- Conditions
- Insomnia Type; Sleep Disorder
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2023-05-01
- Lead Sponsor
- SRI International
- Target Recruit Count
- 115
- Registration Number
- NCT03727906
- Locations
- 🇺🇸
SRI International, Menlo Park, California, United States
- Prev
- 1
- 2
- Next
News
N4 Pharma's Nuvec Delivery System Achieves Targeted RNA Delivery to Lung Cancer Cells
N4 Pharma's Nuvec gene delivery system successfully demonstrated targeted delivery of RNA to non-small cell lung cancer cells in collaboration with SRI International.